logo
Select company
Select metric
$ 189.81MWorking Capital
VS
Market
63
Sector
65
Industry
68
History
72
$ 2.11Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - Working Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - Working Capital Historical data
DateCurrent AssetsCurrent LiabilitiesWorking Capital
6/30/2025$ 221.13M$ 31.32M$ 189.81M
3/31/2025$ 254.84M$ 29.82M$ 225.02M
12/31/2024$ 292.72M$ 35.96M$ 256.77M
9/30/2024$ 274.08M$ 28.66M$ 245.43M
6/30/2024$ 299.53M$ 38.57M$ 260.96M
3/31/2024$ 164.72M$ 31.48M$ 133.24M
12/31/2023$ 194.24M$ 29.82M$ 164.42M
9/30/2023$ 217.57M$ 33.15M$ 184.42M
6/30/2023$ 242.22M$ 35.12M$ 207.1M
3/31/2023$ 100.91M$ 14.05M$ 86.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) Working Capital stands at $ 19M.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average Working Capital has been $ 155.09M.
  • The median Working Capital for TSCAN THERAPEUTICS INC during this period was $ 144.31M
  • TSCAN THERAPEUTICS INC reached its highest Working Capital over the past 5 years at $ 260.96M.
  • The lowest Working Capital recorded by TSCAN THERAPEUTICS INC in the same timeframe $ 19M

TSCAN THERAPEUTICS INC's Working Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Working Capital Benchmarks
CompanyWorking Capital
CRVO : CERVOMED INC $ 33.44MFATE : FATE THERAPEUTICS INC $ 201.72MOVID : OVID THERAPEUTICS INC $ 33.16MARMP : ARMATA PHARMACEUTICALS INC $ -112.56MCBUS : CIBUS INC $ 17.42MCUE : CUE BIOPHARMA INC $ 11.59MVERU : VERU INC $ 9.51MSRZN : SURROZEN INC $ 88.49MPSTV : PLUS THERAPEUTICS INC $ 1.9MKRRO : KORRO BIO INC $ 85.46M

Definition of Working Capital

[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for TSCAN THERAPEUTICS INC is calculated as follows: AssetsC [ $ 36.45M ] - LiabilitesC [ $ 17.45M ]
(=) Working Capital [ $ 19M ]

TCRX - Working Capital, Last 5 years

$ 19M

Minimum

Dec 31, 2020

$ 260.96M

Maximum

Jun 30, 2024

$ 155.09M

Average

$ 144.31M

Median

Working Capital Benchmark Analysis

The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
filtered constituents2.78K
min$ -465.2M
max$ 607.04M
average$ 96.5M
median$ 32.21M
std$ 173.86M